EUVIMEDEUVIMED entdecken
EditorialKommentar

Is Equity Being Traded for Access to Heart Transplant?

Paul A Heidenreich, Eldrin F Lewis, Kiran K Khush

JAMA · 2024

DOI: 10.1001/jama.2024.0812 ↗

Kurz gefasst

Editorial in der Zeitschrift JAMA, 2024. Verfasst von Paul A Heidenreich und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Stanford University School of Medicine, Stanford, California. Hauptthemen laut MEDLINE: Health Equity, Healthcare Disparities, Heart Failure, Heart Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Health EquityHealthcare DisparitiesHeart FailureHeart TransplantationTissue and Organ ProcurementFemaleHumansMaleAsianBlack or African AmericanEthnicityHealth Services AccessibilityHispanic or LatinoRace FactorsSex FactorsSocial ClassUnited StatesWaiting ListsWhite

Autor:innen und Institutionen

  • Department of Medicine, Stanford University School of Medicine, Stanford, California.
  • VA Palo Alto Health Care System, Palo Alto, California.

Zitieren

APA

Heidenreich, P. A., Lewis, E. F., & Khush, K. K. (2024). Is Equity Being Traded for Access to Heart Transplant?. JAMA. https://doi.org/10.1001/jama.2024.0812

Vancouver

Heidenreich PA, Lewis EF, Khush KK. Is Equity Being Traded for Access to Heart Transplant?. JAMA. 2024. doi:10.1001/jama.2024.0812

BibTeX
@article{Heidenreich2024,
  author = {Heidenreich, Paul A and Lewis, Eldrin F and Khush, Kiran K},
  title = {Is Equity Being Traded for Access to Heart Transplant?},
  journal = {JAMA},
  year = {2024},
  doi = {10.1001/jama.2024.0812}
}
Kostenlos starten →